Intel Reveals European Expansion Plans for Intel(R) Health Guide(a)

By Intel, PRNE
Tuesday, May 25, 2010

Next-Generation Remote Patient Monitoring Solution Enables More Personalised Care Management for Chronic and Age-Related Conditions

AMSTERDAM, May 26, 2010 -

    NEWS HIGHLIGHTS

    - Intel is expanding availability of the Intel Health Guide
      across Europe to help address chronic care challenges

    - Intel is working with strategic partners in France, Germany,
      Spain and The Netherlands to bring localised versions of the Intel
      Health Guide to market over the coming year

Intel announced today at the World Congress for Information Technology
that it will be expanding availability of the Intel(R) Health Guide in Europe
and is working with strategic industry partners in France, Germany, Spain and
The Netherlands to bring localised versions of the Intel Health Guide to
market over the coming year.

The Intel Health Guide(b), a regulated device that carries the CE mark
under the EU Medical Device Directive, combines an in-home patient device,
the Intel Health Guide PHS6000, with the Intel Health Care Management Suite,
an online interface that allows clinicians to securely monitor patients in
their homes and manage care remotely. It was designed to help address the
challenges of chronic conditions for patients, their family caregivers and
the healthcare professionals responsible for their care.

"Chronic conditions can account for 70 percent of total health
expenditure in Europe, especially if the conditions are poorly managed.[1]
With the average age of the population in Europe increasing, the number of
people with chronic conditions will increase substantially over the coming
years," said Doug Busch, Vice President and Chief Technical Officer of
Intel's Digital Health Group. "The announcement today represents a major
step forward in addressing new models of care. It demonstrates an industry
commitment to developing the personal health market globally, with the goal
of utilising technology to improve the lives of seniors and people living
with chronic illness."

Addressing the challenges of an ageing population is a goal shared by the
European Commission, which recently adopted its European Action Plan - Ageing
Well in the Information Society. The plan highlights the key role of
information and communication technologies in providing older people with a
better quality of life and in reducing costs for both health and social care.
Between now and 2013, the EU and its member states will invest more than
EUR1 billion in research and innovation in these technologies.

Intel's commitment to addressing the global challenges of an ageing
population

The Intel Health Guide is already commercially available in the United
Kingdom
, United States, Ireland and Australia. In The Netherlands, the
localised language Intel Health Guide is now available and Fujitsu is the
first market reseller to sell the Intel Health Guide. In addition, Intel is
working with the Martini Hospital and CurIT in Groningen to conduct a pilot
project using the Intel Health Guide, funded through local and European
subsidies. In this project, the Intel Health Guide is used for pregnant women
with diabetes.

Intel is also continuing to work with other leading market channel
partners to bring the Intel Health Guide to market globally, and additional
localised European language versions of the Intel Health Guide will be
announced later this year.

    - In France, Intel recently announced its collaboration with
      Orange Healthcare and plans to cooperate on a telehealth pilot project
      with the Moulins-Yzeure Hospital in the Auvergne region of France to
      support care of chronic obstructive pulmonary disease (COPD) patients
      post-discharge using the Intel Health Guide.

    - In Germany, the Asklepios Hospital Group - one of Europe's
      largest private Hospital Groups - recently announced a new
      eHealth-Services strategy and partner model to provide innovative
      eHealth mobile, online and home health services and solutions.
      Asklepios and Intel will cooperate on a joint telehealth pilot project
      to support care of Asklepios patients post-discharge using the Intel
      Health Guide.

    - In Spain, Telefonica is working with Intel on a pilot project and
      plans to announce first findings later this year.

    - In the United Kingdom, BT is the latest market partner selling the
      Intel Health Guide. GE Healthcare and Intel recently announced a sales
      and marketing agreement for the Intel Health Guide in the United
      Kingdom. GE Healthcare already markets the Intel Health Guide in the
      United States.

A comprehensive personal health system

The Intel Health Guide allows clinicians to monitor patients in their
homes and manage care remotely via a secure server. It was designed to help
address the challenges of chronic conditions for patients, their family,
carers and the health care professionals responsible for their care. The
system offers interactive tools for personalised care management and includes
vital signs collection, patient reminders, surveys, multimedia educational
content, and feedback and communications tools such as video conferencing and
email notifications. It can connect to specific models of wired and wireless
medical devices, including blood pressure monitors, glucose meters, pulse
oximeters, peak flow meters and weight scales.

Using a secure server, health care professionals can remotely review and
act on this information. As a result, clinicians have ongoing access to data
so that they can better manage each patient's conditions. Patients benefit
from customised care in the comfort of their home and can also monitor their
health status and communicate with care teams.

The localised versions of the Intel Health Guide are
Continua-compliant, signalling Intel's commitment to standardisation and
interoperability. The Continua-compliant English language version will be
released later this year. In June 2006, Intel and other founding member
companies announced the formation of the Continua Health Alliance. Today, the
Alliance has over 200 members from business and representative organisations.
This open industry group seeks to ensure that health technologies are
compatible, meet common standards and work seamlessly together. The main
focus of the Alliance is on creating guidelines for industry across three
major categories: chronic disease management, monitoring the health and
healthcare needs of ageing people and proactive health and fitness.

About Intel

Intel (NASDAQ: INTC), the world leader in silicon innovation, develops
technologies, products and initiatives to continually advance how people work
and live. Additional information about Intel is available at
www.intel.com/pressroom and blogs.intel.com.

For more information on the Intel Health Guide, visit
www.intel.com/healthcare/telehealth. To learn more about Intel in
healthcare, go to www.intel.com/healthcare.

Intel is a trademark of Intel Corporation or its subsidiaries in the
United States
and other countries.

* Other names and brands may be claimed as the property of others

(a) The Intel Health Guide requires an internet connection to enable
communications with the patient's care team and back-end data hosting. The
Intel Health Guide is intended for use by patients under the guidance of a
healthcare professional and is not intended for emergency medical
communications or real-time patients monitoring.

(b) The Intel Health Guide is designed to be used by health care
professionals to manage their patients at home and is not currently available
for general consumer purchase.

Reference [1] Eurostat. Available at:
epp.eurostat.ec.europa.eu/portal/page?_pageid=1090,30070682,1090_33076
576&_dad=portal&_schema=PORTAL

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

CONTACTS: Diana Kaaserer, Intel Corporation, +49-8999143860, diana.kaaserer at intel.com ; Bea Solomon, Hill and Knowlton, +44-2074133188, bsolomon at hillandknowlton.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :